Follow Up Study for Treatment of Parkinson's Disease With Subthalamic Deep Brain Stimulation
NCT ID: NCT03230331
Last Updated: 2020-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2017-07-24
2019-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Deep Brain Stimulation of the Subthalamic Nucleus (STN) and Cognitive Control
NCT00917722
Controlled Trial With Deep Brain Stimulation in Patients With Early Parkinson's Disease
NCT00354133
Deep Brain Stimulation Follow-up After 10 Years
NCT01575132
The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease
NCT02253043
Asymmetric Targeted DBS for PD With PIGD
NCT05397340
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
STN DBS
Parkinson's disease (PD) patients who underwent deep brain stimulation (DBS) of the subthalamic nucleus (STN)
No interventions assigned to this group
CONTROL
Parkinson's disease (PD) patients received optimized medical treatment according to published evidence based guidelines
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Disease duration longer than 15 years
* Had STN deep brain stimulation implant more than 10 years
* Available and willing to be followed-up according to study protocol
Exclusion Criteria
* Epilepsy
* Pregnant female
* History of severe neuropsychiatric disease
* Patients are taking part in other clinical trials in recent several months
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruijin Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haiyan Zhou
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Haiyan Zhou
Role: PRINCIPAL_INVESTIGATOR
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Dianyou Li
Role: PRINCIPAL_INVESTIGATOR
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Bomin Sun
Role: PRINCIPAL_INVESTIGATOR
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Wei Hu
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FOGSTN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.